Mural Oncology PLC MURA
We take great care to ensure that the data presented and summarized in this overview for Mural Oncology plc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MURA
Top Purchases
Top Sells
About MURA
Insider Transactions at MURA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2024
|
Caroline Loew Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,763
-1.15%
|
$8,289
$3.4 P/Share
|
|
Nov 07
2024
|
Vicki L Goodman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,069
-6.94%
|
$15,207
$3.33 P/Share
|
|
Oct 31
2024
|
Adam D. Cutler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,421
-9.41%
|
$22,263
$3.41 P/Share
|
|
Aug 14
2024
|
Susan Altschuller |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$30,000
$3.21 P/Share
|
|
Jul 18
2024
|
Maiken Keson Brookes |
SELL
Open market or private sale
|
Direct |
2,157
-4.69%
|
$6,471
$3.41 P/Share
|
|
Jul 08
2024
|
Caroline Loew Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,531
-4.95%
|
$25,062
$2.91 P/Share
|
|
Mar 01
2024
|
Caroline Loew Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,475
+16.08%
|
-
|
|
Mar 01
2024
|
Maiken Keson Brookes |
BUY
Grant, award, or other acquisition
|
Direct |
16,800
+26.75%
|
-
|
|
Dec 14
2023
|
Caroline Loew Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
204,447
+50.0%
|
-
|
|
Dec 14
2023
|
Maiken Keson Brookes |
BUY
Grant, award, or other acquisition
|
Direct |
29,207
+50.0%
|
-
|
|
Dec 14
2023
|
Adam D. Cutler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,859
+50.0%
|
-
|
|
Dec 14
2023
|
Vicki L Goodman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,018
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
75.3K
Shares
From
3
Insiders
| Open market or private purchase | 10K shares |
|---|---|
| Grant, award, or other acquisition | 65.3K shares |
Sell / Disposition
29.9K
Shares
From
4
Insiders
| Open market or private sale | 29.9K shares |
|---|